← Eichor
Study identifier: NCT06575738 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

Condition: Obesity · Adolescent Obesity · Body-Weight Trajectory  ·  Sponsor: University of Colorado, Denver

PhasePhase 1
Planned participants40
Who can joinAll sexes, 12 Years to 24 Years
Healthy volunteersNo

About this study

The study plans to learn more about what happens to the body after bariatric surgery in people 12 to 24 years old. The study aims to understand why people respond differently to bariatric surgery and how to define success beyond weight loss alone. The study also plans to learn more about whether a medication (semaglutide or tirzepatide) can help people 12 to 24 years old who, between 6 and 24 months after bariatric surgery, have not lost as much weight as expected.

This description comes directly from the study's public registry record.

Talk to the study team

Jaime Moore, MD MPH  ·  303-724-8419  ·  jaime.moore@cuanschutz.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Childrens Hospital ColoradoAurora, Colorado, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06575738